Evrofarma SA (ATH:EVROF)

Evrofarma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	49	49	25	16	10	12
Market Cap Growth	89.47%	99.45%	50.83%	68.54%	-21.76%	-4.61%
Enterprise Value	60	61	41	37	32	32
Last Close Price	3.60	3.61	1.78	1.14	0.68	0.87
PE Ratio	13.96	14.00	10.86	7.45	6.86	-
PS Ratio	1.00	1.00	0.54	0.34	0.22	0.34
PB Ratio	2.38	2.39	1.39	1.01	0.69	0.99
P/TBV Ratio	2.42	2.43	1.40	1.01	0.70	1.00
P/FCF Ratio	-	-	6.00	30.73	16.23	-
P/OCF Ratio	13.71	13.75	4.62	5.22	3.69	-
EV/Sales Ratio	1.21	1.23	0.91	0.77	0.71	0.87
EV/EBITDA Ratio	8.24	8.45	7.08	7.04	8.59	19.49
EV/EBIT Ratio	11.43	11.60	10.15	10.22	14.28	137.87
EV/FCF Ratio	-117.33	-	10.04	69.98	53.69	-
Debt / Equity Ratio	0.83	0.83	0.95	1.20	1.52	1.69
Debt / EBITDA Ratio	2.35	2.35	2.87	3.64	5.63	12.75
Debt / FCF Ratio	-	-	4.11	36.57	35.63	-
Net Debt / Equity Ratio	0.51	0.51	0.77	1.16	1.42	1.67
Net Debt / EBITDA Ratio	1.46	1.46	2.33	3.55	5.32	12.89
Net Debt / FCF Ratio	-20.62	-20.62	3.30	35.34	33.24	-5.07
Asset Turnover	0.95	0.95	0.96	1.01	0.95	0.79
Inventory Turnover	5.39	5.39	5.36	6.91	9.17	9.89
Quick Ratio	1.57	1.57	0.59	0.75	1.04	1.37
Current Ratio	2.23	2.23	0.98	1.25	1.48	1.67
Return on Equity (ROE)	18.32%	18.32%	13.39%	14.56%	10.66%	-2.78%
Return on Assets (ROA)	6.24%	6.24%	5.33%	4.75%	2.96%	0.31%
Return on Invested Capital (ROIC)	13.06%	13.00%	9.68%	8.61%	6.22%	0.71%
Return on Capital Employed (ROCE)	11.40%	11.40%	13.60%	10.70%	6.20%	0.60%
Earnings Yield	7.16%	7.14%	9.21%	13.42%	14.58%	-2.85%
FCF Yield	-1.03%	-1.03%	16.68%	3.26%	6.16%	-33.37%
Dividend Yield	1.39%	-	-	4.38%	-	-
Payout Ratio	23.26%	19.29%	29.83%	-	-	-
Buyback Yield / Dilution	0.04%	-	-	-0.05%	0.02%	-
Total Shareholder Return	1.43%	-	-	4.33%	0.02%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.